Pre-op assessment should consider interactions between demographic and ocular factors

Article

Corneal refractive surgery may be more successful in eyes in which the cylinder mainly originates from the anterior cornea; therefore, in candidates for refractive surgery, surgeons should carefully assess the interaction between topographic, refractive and ocular residual astigmatism (ORA) to identify those at high risk for having significant differences between subjective cylinder and topographic astigmatism.

Corneal refractive surgery may be more successful in eyes in which the cylinder mainly originates from the anterior cornea; therefore, in candidates for refractive surgery, surgeons should carefully assess the interaction between topographic, refractive and ocular residual astigmatism (ORA) to identify those at high risk for having significant differences between subjective cylinder and topographic astigmatism. These conclusions were made by the authors of a study recently published in the Journal of Cataract & Refractive Surgery.

Researchers included 2991 eyes from 2991 myopic patients scheduled for LASIK to evaluate the influence of age, sex, ocular dominance, subjective cylinder and topographic astigmatism, subjective sphere and myopic pupil size on preexisting ocular residual astigmatism. A total of 46% of eyes had an ORA of 1.00 D or more.

Using ordinary least square estimations and odds ratios, researchers determined that negative predictors of the degree of preoperative ORA included subjective sphere, male sex and dominant eye, and that increasing age and larger mesopic pupils did not indicate ORA orientation. Further, with-the-rule astigmatism meridian was more likely to occur in eyes with low ORA, and oblique and against-the-rule meridians were related to high ORA.

To access this study, click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.